Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kathrin Schramm
Observed names:
K. Schramm,
Schramm, Kathrin
Institutions:
German Cancer Research Center,
Heidelberg University,
University Hospital Heidelberg,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Deutsches Konsortium für Translationale Krebsforschung
show all 6
Observed institutions:
German Cancer Research Center,
Heidelberg University,
University Hospital Heidelberg,
National Center for Tumor Diseases,
Hopp Children's Cancer Center Heidelberg,
Deutsches Konsortium für Translationale Krebsforschung
show all 6
ORCID:
0009-0006-7355-6378
Observed ORCID:
0009-0006-7355-6378
OpenAlex ID:
A5109592087
Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling
2015
·
Marc Zuckermann
, Volker Hovestadt
, et al.
·
Nature Communications
·
298
PDF
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
2021
·
Cornelis M. van Tilburg
, Elke Pfaff
, et al.
·
Cancer Discovery
·
263
PDF
Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
2016
·
Sebastian Bender
, Susanne Gröbner
, et al.
·
Nature Medicine
·
233
PDF
Genomic ALK alterations in primary and relapsed neuroblastoma
2023
·
Carolina Rosswog
, Jana Fassunke
, et al.
·
British Journal of Cancer
·
74
PDF
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
2022
·
Heike Peterziel
, Nora Jamaladdin
, et al.
·
npj Precision Oncology
·
65
PDF
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
2022
·
Michaela-Kristina Keck
, Martin Sill
, et al.
·
Acta Neuropathologica
·
43
PDF
DECIPHER pooled shRNA library screen identifies PP2A and FGFR signaling as potential therapeutic targets for diffuse intrinsic pontine gliomas
2019
·
Kathrin Schramm
, Murat Iskar
, et al.
·
Neuro-Oncology
·
37
PDF
Nuclear Calcium Buffering Capacity Shapes Neuronal Architecture
2015
·
Daniela Mauceri
, Anna M. Hagenston
, et al.
·
Journal of Biological Chemistry
·
36
PDF
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
2022
·
Charlotte Gatzweiler
, Johannes Ridinger
, et al.
·
Cancers
·
33
PDF
Outcome of Children and Adolescents With Relapsed/Refractory/Progressive Malignancies Treated With Molecularly Informed Targeted Drugs in the Pediatric Precision Oncology Registry INFORM
2023
·
Anna-Elisa Heipertz
, Kristian W. Pajtler
, et al.
·
JCO Precision Oncology
·
32
PDF
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
2020
·
Lisa Mayr
, Armin S. Guntner
, et al.
·
Journal of Personalized Medicine
·
31
PDF
Oncogene aberrations drive medulloblastoma progression, not initiation
2025
·
Konstantin Okonechnikov
, Piyush Joshi
, et al.
·
Nature
·
24
Feasibility and antitumour activity of the FGFR inhibitor erdafitnib in three paediatric CNS tumour patients
2024
·
Natalia Stepien
, Lisa Mayr
, et al.
·
Pediatric Blood & Cancer
·
21
PDF
A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
2024
·
Tatsiana Ryl
, Elena Afanasyeva
, et al.
·
Communications Biology
·
16
PDF
The pediatric precision oncology study INFORM: Clinical outcome and benefit for molecular subgroups.
2020
·
Cornelis Martinus van Tilburg
, Elke Pfaff
, et al.
·
Journal of Clinical Oncology
·
15
Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene
2025
·
Ninad Oak
, Wenan Chen
, et al.
·
Journal of Clinical Oncology
·
10
Genomic Evolution and Personalized Therapy of an Infantile Fibrosarcoma Harboring anNTRKOncogenic Fusion
2022
·
Anne Thorwarth
, Kerstin Haase
, et al.
·
JCO Precision Oncology
·
7
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid Tumors
2025
·
Dina ElHarouni
, Rosa Hernansaiz-Ballesteros
, et al.
·
Cancer Research
·
5
PDF
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM
2025
·
Elke Pfaff
, Kathrin Schramm
, et al.
·
Acta Neuropathologica
·
4
PDF
Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma
2024
·
Tatsiana Ryl
, Elena Afanasyeva
, et al.
·
Communications Biology
·
4
PDF
Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification
2023
·
Michaela-Kristina Keck
, Martin Sill
, et al.
·
Acta Neuropathologica
·
4
PDF
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10
2025
·
Steffen Hirsch
, Ramin Rahmanzade
, et al.
·
Acta Neuropathologica
·
3
The impact of methylome analysis on the diagnosis and treatment of CNS tumours in children and adolescents: A population-based study in Greece
2024
·
Maria Filippidou
, Stavros Glentis
, et al.
·
EJC Paediatric Oncology
·
2
PDF
Cell-state plasticity drives heterogeneity in Group 3/4 medulloblastoma
2024
·
Piyush Joshi
, Patricia Benites Goncalves da Silva
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
Secondary Biphenotypic Acute Leukemia Following Rosai-Dorfman-Disease A Coincidence?
2021
·
Anne Thieme
, Katja Maurus
, et al.
·
Klinische Pädiatrie
·
2
PDF
Show more works
View as search
Works count:
82
Citation count:
1,269
H-index:
15
I10-index:
16
Year
Topic
Type